drugset / Trial / NCT00707473

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

NCT00707473 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well docetaxel, cisplatin and fluorouracil work in treating patients with previously untreated stage II-IV nasal cavity and/or paranasal sinus cancer. Drugs used in chemotherapy, such as docetaxel, cisplatin and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Timeline

Start
2008-06-16
Primary completion
2026-06-01
Completion
2026-06-01

Outcome

Outcome not reported

Stopped: “\<75% participation”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Cisplatin Other / unclassified — Intravenous
Subject Docetaxel Small molecule — Intravenous
Subject fluorouracil Small molecule — Intravenous